ArticleJournal of ginseng research2026
Effects of Korean red ginseng on the HIV-1
Article in Journal of ginseng research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Korean Red Ginseng (KRG) and KRG combination therapies have demonstrated long-term benefits in HIV-1-infected patients. This study aimed to assess whether long-term KRG treatment influences sequence length (SL) and CpG700 content in the HIV-1 Materials and methods: 880 wild-type, full-length Results: In the whole cohort, the correlation between SL and disease duration (DD) from diagnosis, both before and during ART, was significantly stronger in KE patients than in KN patients (P < 0.01), whereas CpG700 showed no such correlation with DD or KRG. To reduce selection bias, we further analyzed only patients with two or more samples sequenced samples; in this subgroup, both SL and CpG700 demonstrated significant correlations with DD and KRG, with correlation strength increasing as follow-up duration increased. Notably, in the high-intake group receiving prolonged, intensive KRG treatment, CpG700 correlated more strongly with KRG than with DD or SL. Conclusion:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.